GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Haohai Biological Technology Co Ltd (HKSE:06826) » Definitions » Pre-Tax Income

Shanghai Haohai Biological Technology Co (HKSE:06826) Pre-Tax Income : HK$554 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Shanghai Haohai Biological Technology Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Shanghai Haohai Biological Technology Co's pretax income for the three months ended in Mar. 2024 was HK$124 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was HK$554 Mil. Shanghai Haohai Biological Technology Co's pretax margin was 17.67%.

During the past 10 years, Shanghai Haohai Biological Technology Co's highest Pretax Margin was 48.30%. The lowest was 11.21%. And the median was 30.60%.


Shanghai Haohai Biological Technology Co Pre-Tax Income Historical Data

The historical data trend for Shanghai Haohai Biological Technology Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haohai Biological Technology Co Pre-Tax Income Chart

Shanghai Haohai Biological Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 483.32 304.69 468.54 263.24 555.92

Shanghai Haohai Biological Technology Co Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 127.68 150.62 149.70 130.06 124.02

Competitive Comparison of Shanghai Haohai Biological Technology Co's Pre-Tax Income

For the Biotechnology subindustry, Shanghai Haohai Biological Technology Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haohai Biological Technology Co's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Haohai Biological Technology Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Shanghai Haohai Biological Technology Co's Pre-Tax Income falls into.



Shanghai Haohai Biological Technology Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Shanghai Haohai Biological Technology Co's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=479.488+0+-7.979+85.021+-0.60599999999999
=556

Shanghai Haohai Biological Technology Co's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=109.743+0+-2.9+19.439+-2.264
=124

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$554 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Haohai Biological Technology Co  (HKSE:06826) Pre-Tax Income Explanation

Shanghai Haohai Biological Technology Co's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=124.018/701.745
=17.67%

During the past 10 years, Shanghai Haohai Biological Technology Co's highest Pretax Margin was 48.30%. The lowest was 11.21%. And the median was 30.60%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Haohai Biological Technology Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Haohai Biological Technology Co (HKSE:06826) Business Description

Traded in Other Exchanges
Address
No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. It is also engaged in the research and development of biological engineering, pharmaceutical and ophthalmology products, and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.
Executives
Morgan Stanley 2201 Interest of corporation controlled by you
Dalton Investments Llc 2102 Investment manager
The Bank Of New York Mellon Corporation 2201 Interest of corporation controlled by you
Templeton Investment Counsel, Llc 2102 Investment manager
Kabouter Management Llc 2102 Investment manager
Royal Bank Of Canada 2201 Interest of corporation controlled by you
Kabouter International Insight Fund, Llc 2102 Investment manager
Prudence Investment Management (hong Kong) Limited 2102 Investment manager

Shanghai Haohai Biological Technology Co (HKSE:06826) Headlines

No Headlines